<h2>Florida Governor Signs Law Revoking Medical Cannabis Cards for Drug Offenses</h2>
<p>In a significant move impacting the cannabis community, Florida Governor Ron DeSantis has signed into law SB 2514, which targets medical cannabis cardholders convicted of drug-related crimes. This legislation empowers the Florida Department of Health to revoke the state's medical marijuana registry registration for those entering guilty pleas or condemned of specific offenses.</p>
<p>However, there remains a path to redemption for those affected. Once individuals have completed all the terms related to their convictions, they can reapply to regain their place in the medical cannabis program. This law signals a stricter approach to cannabis regulation in the Sunshine State while still offering an opportunity for reintegration.</p>
<h2>Missouri Launches Cannabis Testing and Sampling Initiative</h2>
<p>The Missouri Department of Health and Human Services, through its Division of Cannabis Regulation (DCR), has unveiled a statewide cannabis testing and sampling initiative. Effective from July 1, this program follows regulation 19 CSR 100-1.110(12), which is dedicated to enhancing product safety, ensuring precise labeling, and maintaining testing standards in Missouri’s growing cannabis industry.</p>
<p>The Missouri State Public Health Laboratory has been appointed as the official testing facility, though alternate licensed laboratories can also conduct tests. This initiative is expected to bolster consumer confidence and contribute to the integrity and reliability of the state's cannabis market.</p>
<h2>Mid-Year Review: Cannabis and Hemp Regulations Across the U.S.</h2>
<p>As we reach the mid-point of 2025, it’s crucial to examine how recent regulatory shifts are reshaping the cannabis and hemp landscape in the U.S. Notable developments include new THC and CBD regulations in Louisiana, evolving hemp-derived product policies in California, legalization efforts in Pennsylvania, medical cannabis advancements in Virginia, and changes for hemp products in Missouri.</p>
<p>These adjustments reflect a broader trend toward refining and expanding cannabis laws, impacting everything from consumer access to market dynamics across state lines. Canna Daily News continues to provide thorough coverage and insights into these unfolding regulatory landscapes.</p>
<h2>Dallas Officials Halt Voter-Approved Cannabis Depenalization</h2>
<p>Officials in Dallas, Texas have blocked the enactment of the Dallas Freedom Act, a voter-backed cannabis depenalization measure intended to curtail low-level cannabis possession arrests. Last November, Dallas residents voted 67% in favor of this ordinance aimed at limiting local law enforcement's authority on minor cannabis infractions.</p>
<p>Despite significant voter support, this halt raises questions about the influence of local governance on cannabis reform and sets the stage for further debate and advocacy within the community. This ongoing saga underscores the complexities of aligning civic will with legal frameworks in the cannabis realm.</p>
<h2>Study Reveals Higher THC Label Accuracy in Concentrates vs. Flower</h2>
<p>A recent study titled, “Accuracy of Labeled THC Potency Across Flower and Concentrate Cannabis Products,” sheds light on the discrepancies in THC labeling. The research found that 56.7% of cannabis flower products matched their labeled THC content within a 15% margin. Conversely, concentrate products demonstrated a 96% accuracy in THC labeling.</p>
<p>Yasha Kahn, co-founder of MCR Labs and guest on Canna Daily News's Noid Knowledge podcast, presented his FOIA project findings, which highlight significant inconsistencies in potency and mold testing data across 37 states. This underscores the compelling need for stricter testing protocols and accurate product labeling to ensure consumer trust and regulatory compliance.</p>
<p>#CannabisNews #CBDTrends #CannabisRegulations #CannabisIndustryUpdates #HempInnovations</p>